News

Kindeva’s acquisition of iPharma will increase the company’s inhalation formulation outsourcing capabilities.

Aizon Digitize is designed to help life science manufacturers transition data from paper to digital.

FDA is at a pivotal moment because of important gains in medical treatment based on science.

Connect in Pharma will host an awards ceremony to showcase innovations in sustainable pharmaceutical packaging.

The agency will review laboratory study and CMC data on the bivalent vaccine that targets two strains of the SARS-CoV-2 virus.

Lessons learned from the COVID-19 pandemic about the benefits of international collaboration were discussed in a May 2022 workshop.

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.

Orbit Discovery has been awarded the Innovate UK Grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery.

FDA has issued an Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines in children as young as six months old.

Batavia Biosciences is expanding its headquarters and R&D capabilities in its Netherlands facility.

Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.

SCHOTT is planning to triple its ready-to-use vial production capacity in the United States to meet increasing demand for storing injectable drugs.

Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.

Measure tackles infant formula, cosmetics, diagnostics plus drug development and access.

Humanigen and PCI Pharma Servicesare partnering up for the commercialization of lenzilumab.

MHRA has been accepted as a full member of three international work-sharing partnerships aimed at making sure medicines and medical devices are regulated safely and efficiently across the world.

NICE has published its final draft guidance recommending the use of Vazkepa (icosapent ethyl) in adults to reduce heart attacks and strokes.

Merck has entered into a collaboration with Agilent Technologies with the aim of filling the industry gap in PAT for downstream processing.

A new polymer surface material has been invented by researchers in Sweden that uses electrical signals to both capture and release biomolecules.

Exothera, LogicBioTherapeutics, and Polyplus-transfection, are collaborating on the development of a scalable AAV manufacturing platform.

CPHI China and P-MEC China has opened its online partnering platform after China experienced gains in the CPHI Pharma Index.

UK researchers have discovered a gene involved in chronic pain, which has created a new treatment target.

The draft ICH Q9(R1) document details the importance of quality risk management principles.

The new draft guidance describes a standards recognition program for regenerative medicine therapies.

Yourway intends to construct a new manufacturing facility in the Dublin Airport Logistics Park.

The deal will see Spectrum market and distribute ANGUS’ biologics grade buffers in the United States and Canada.

Precision BioSciences has released clinical trial data on CAR T therapy candidates PBCAR0191, PBCAR19B, and PBCAR269A.

Moderna’s mRNA-1273.214 booster candidate exhibited an eight-fold boost in neutralizing geometric mean titers against Omicron.

REGENXBIO has opened a new in-house facility at its headquarters in Rockville, Md., that will be used to manufacture AAV gene therapies at commercial scale.

In the report, the agency presents the activities it accomplished in 2021 to protect and promote public health.